61 | Approaches to NSCLC with or without targetable mutations 2023-02-17 |
Play |
62 | CAR-T in solid tumors: advances and challenges in targeting CLDN18.2, HER2 and STEAP 1 2023-02-10 |
Play |
63 | ASCO GI 2023: Bile duct cancer updates with Ghassan Abou-Alfa 2023-02-03 |
Play |
64 | Breast Cancer Sessions: Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons 2023-01-25 |
Play |
65 | Updates in cervical cancer 2023-01-20 |
Play |
66 | Resistance to immune checkpoint inhibitors in NSCLC 2023-01-13 |
Play |
67 | Impact of race on breast cancer outcomes 2023-01-06 |
Play |
68 | Immunotherapy updates in GI cancer 2022-12-23 |
Play |
69 | Updates from ESMO Asia 2022 2022-12-16 |
Play |
70 | Updates in EGFR-mutant NSCLC 2022-12-02 |
Play |